Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Khirurgiia (Mosk) ; (2): 70-74, 2015.
Artigo em Russo | MEDLINE | ID: mdl-26031823

RESUMO

It was performed a comparative research of remote results including local status and life quality of simultaneous surgical treatment in 64 patients with postoperative ventral hernias (W1-W4) and obesity (1-3 degrees). It was compared advanced hernioalloplasty with new synthetic materials including Prolene-Monocryl-composite mesh and absorbable adhesion barrier INTERCEED (TC7) in combination with abdominoplasty and hernioalloplasty with the same materials. It was concluded that simultaneous hernioalloplasty and abdominoplasty contributed statistically significant (p < 0.01) decreasing of number of recurrent hernias in 2 times, body mass index and body mass on 24% in comparison with single alloplasty.


Assuntos
Abdominoplastia/métodos , Hérnia Ventral/cirurgia , Herniorrafia/métodos , Obesidade/cirurgia , Complicações Pós-Operatórias/cirurgia , Telas Cirúrgicas , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Seguimentos , Hérnia Ventral/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Obesidade/complicações , Qualidade de Vida , Fatores de Tempo , Resultado do Tratamento , Adulto Jovem
2.
Khirurgiia (Mosk) ; (7): 17-9, 1998.
Artigo em Russo | MEDLINE | ID: mdl-9791964

RESUMO

Effectiveness of lymphological methods of treatment (LT) of endogenic intoxication (EI) developed by the author (endolymphatic anticoagulatory, improving rheology and microcirculation, antibacterial, detoxicating, enzyme-inhibiting, myo- and lymphostimulating, immunomodulating and hepatotropic) was studied in 210 patients with peritonitis divided into two groups of 105 patients each: in the control group a conventional postoperative treatment was carried out, in the study group--LT. Toxicity of the blood was determined by the level of medium-size molecules and leukocytic index of intoxication on postoperative day 1, 3, 5, 7 and 14. It was established that LT which creates conditions for simultaneous sanation of blood and lymphatic bed, interstitial space, the inflammation focus promotes total detoxication of the body with almost complete elimination of EI on postoperative day 5-7. In conventional treatment EI persisted for 7-14 days after operation.


Assuntos
Peritonite/terapia , Cuidados Pós-Operatórios/métodos , Adjuvantes Imunológicos/administração & dosagem , Adjuvantes Imunológicos/uso terapêutico , Antibacterianos , Anticoagulantes/administração & dosagem , Anticoagulantes/uso terapêutico , Quimioterapia Combinada/administração & dosagem , Quimioterapia Combinada/uso terapêutico , Inibidores Enzimáticos/administração & dosagem , Inibidores Enzimáticos/uso terapêutico , Seguimentos , Humanos , Injeções Intralinfáticas , Resultado do Tratamento
3.
Anesteziol Reanimatol ; (3): 61-4, 1998.
Artigo em Russo | MEDLINE | ID: mdl-9693438

RESUMO

Bacterial aggression and tissue destruction during experimental peritonitis cause progressive disorders of blood and lymph microcirculation, paralleled by increase of the coagulation potential of the blood and lymph, activation (during the first 12 hr) of the drainage function of the lymph system, followed in 24 h by a drop of lymph flow and its complete blocking in 48-72 h. This is caused by disseminated microhemo- and lymphothrombosis with decompensation of the drainage and transporting functions of the lymph system during this period of the disease. Lymphogenic effect of endolymphatic stimulation by drugs in experimental peritonitis is notably (by 1.8-4.5 times) higher than the effect of routine lymph stimulation with the same drugs and their combinations.


Assuntos
Adjuvantes Imunológicos/farmacologia , Anti-Inflamatórios não Esteroides/farmacologia , Anticoagulantes/farmacologia , Fármacos Gastrointestinais/farmacologia , Linfa/efeitos dos fármacos , Sistema Linfático/fisiopatologia , Peritonite/fisiopatologia , Vasodilatadores/farmacologia , Adjuvantes Imunológicos/uso terapêutico , Animais , Anti-Inflamatórios não Esteroides/uso terapêutico , Anticoagulantes/uso terapêutico , Cães , Fármacos Gastrointestinais/uso terapêutico , Linfa/fisiologia , Peritonite/tratamento farmacológico , Trombose/etiologia , Fatores de Tempo , Vasodilatadores/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...